Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding DomainHuan Ma, Tengchuan Jin, Xiaowen Hu et al.|Journal of Virology|2021Cited by 80
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including OmicronHuan Ma, Tengchuan Jin, Xinghai Zhang et al.|Cell Research|2022Cited by 41
Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital dischargeHuan Ma, Tengchuan Jin, Dan Zhao et al.|Science China Life Sciences|2020Cited by 30
Decline of SARS-CoV-2 specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital dischargeHuan Ma, Tengchuan Jin, Dan Zhao et al.|medRxiv|2020Cited by 9
Potent in vitro Neutralization of SARS-CoV-2 by Hetero-bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding DomainHuan Ma, Tengchuan Jin, Weihong Zeng et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 3